1111P A randomised phase II study of intermittent versus continuous dosing of targeted therapy in patients with BRAFV600 mutant advanced melanoma (INTERIM) von Gupta, A., Matin, R.N., Dayimu, A., Nobes, J., Board, R.E., Payne, M., Rao, A.R., Fusi, A., Danson, S., Eccles, B.K., Carser, J., O'Hanlon Brown, C., Steven, N., Burghel, G.J., Demain, L., Baker, E.C., Wulff, J., Twelves, S., Middleton, M.R., Corrie, P.G.

Volltext

A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM) von Dayimu, A, Gupta, A, Matin, R.N, Nobes, J, Board, R, Payne, M, Rao, A, Fusi, A, Danson, S, Eccles, B, Carser, J, Brown, C.O, Steven, N, Bhattacharyya, M, Brown, E, Gonzalez, M, Highley, M, Pickering, L, Kumar, S, Waterston, A, Burghel, G, Demain, L, Baker, E, Wulff, J, Qian, W, Twelves, S, Middleton, M, Corrie, P

Volltext bestellen

Sample size determination for prediction models via learning‐type curves von Dayimu, Alimu, Simidjievski, Nikola, Demiris, Nikolaos, Abraham, Jean

Volltext

Trajectories of Lipids Profile and Incident Cardiovascular Disease Risk: A Longitudinal Cohort Study von Dayimu, Alimu, Wang, Chunxia, Li, Jiangbing, Fan, Bingbing, Ji, Xiaokang, Zhang, Tao, Xue, Fuzhong

Volltext

Small-area spatial statistical analysis of malaria clusters and hotspots in Cameroon;2000-2015 von Tewara, Marlvin Anemey, Mbah-Fongkimeh, Prisca Ngetemalah, Dayimu, Alimu, Kang, Fengling, Xue, Fuzhong

Volltext

Body Mass Index Trajectories During Young Adulthood and Incident Hypertension: A Longitudinal Cohort in Chinese Population von Fan, Bingbing, Yang, Yachao, Dayimu, Alim, Zhou, Guangshuai, Liu, Yanxun, Li, Shengxu, Chen, Wei, Zhang, Tao, Xue, Fuzhong

Volltext

A comprehensive evaluation on the associations between hearing and vision impairments and risk of all-cause and cause-specific dementia: results from cohort study, meta-analysis an... von Jiang, Fan, Dong, Qiuyue, Wu, Sijia, Liu, Xinhui, Dayimu, Alimu, Liu, Yingying, Ji, Hanbing, Wang, Le, Liu, Tiemei, Li, Na, Li, Xiaofei, Fu, Peipei, Jing, Qi, Zhou, Chengchao, Li, Hongkai, Xu, Lei, Chen, Shanquan, Wang, Haibo

Volltext

Trajectories of Haemoglobin and incident stroke risk: a longitudinal cohort study von Dayimu, Alimu, Qian, Wendi, Fan, Bingbing, Wang, Chunxia, Li, Jiangbing, Wang, Shukang, Ji, Xiaokang, Zhou, Guangshuai, Zhang, Tao, Xue, Fuzhong

Volltext

Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington’s disease (FELL-HD): a phase II, single-centre, open-label, dose-finding t... von Andresen, Katie, Cutting, Emma, Apostolopoulos, Dimitrios, Evans, Amy H, Oakley, Laura, Dayimu, Alimu, Demiris, Nikolaos, Bongaerts, Katherine, Staples, Robyn, Gooding, Wendy, Rubinsztein, David C, Barker, Roger A

Volltext

Global evolving patterns and cross-country inequalities of inflammatory bowel disease burden from 1990 to 2019: a worldwide report von Cao, Lina, Dayimu, Alimu, Guan, Xiao, Duan, Miao, Zeng, Shuyan, Wang, Hui, Zong, Jiahao, Sun, Chunhua, Yang, Xiaorong, Yang, Xiaoyun

Volltext

Long-term functional outcomes of hearing and speech rehabilitation efficacy among paediatric cochlear implant recipients in Shandong, China von Jiang, Fan, Alimu, Dayimu, Qin, Wen-Zhe, Kupper, Hannah

Volltext

Trajectories of early to mid-life adulthood BMI and incident diabetes: the China Health and Nutrition Survey von Lv, Jiali, Fan, Bingbing, Wei, Mengke, Zhou, Guangshuai, Dayimu, Alim, Wu, Zhenyu, Su, Chang, Zhang, Tao

Volltext

NIMG-55. PREDICTING SITES OF TUMOR PROGRESSION IN THE INVASIVE MARGIN OF GLIOBLASTOMAS (PRAM-GBM STUDY): AN INTERIM ANALYSIS OF A MULTI-CENTER IMAGING BIOMARKER STUDY von Price, Stephen, Mayrand, Roxanne, Wan, Yizhou, Cream, Lynn, Cook, Julia, Dayimu, Alimu, Jenkinson, Michael, Varma, Anil, Ashkan, Keyoumars, Thomson, Simon, Smith, Stuart, Demiris, Nikolaos, Matys, Tomasz, Li, Chao

Volltext

Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy von Lu, Yuan, Su, Quanping, Li, Ming, Dayimu, Alimu, Dai, Xiaoyu, Wang, Zhiheng, Che, Fengyuan, Xue, Fuzhong

Volltext

Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma von Dayimu, Alimu, Di Lisio, Lorena, Anand, Shubha, Roca-Carreras, Isart, Qian, Wendi, Al-Mohammad, Abdulrahman, Basu, Bristi, Valle, Juan W., Jodrell, Duncan, Demiris, Nikos, Corrie, Pippa

Volltext

A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM) von Dayimu, Alimu, Gupta, Avinash, Matin, Rubeta N., Nobes, Jenny, Board, Ruth, Payne, Miranda, Rao, Ankit, Fusi, Alberto, Danson, Sarah, Eccles, Bryony, Carser, Judith, Brown, Ciara O’Hanlon, Steven, Neil, Bhattacharyya, Madhumita, Brown, Ewan, Gonzalez, Michael, Highley, Martin, Pickering, Lisa, Kumar, Satish, Waterston, Ashita, Burghel, George, Demain, Leigh, Baker, Eleanor, Wulff, Jerome, Qian, Wendi, Twelves, Sophie, Middleton, Mark, Corrie, Pippa

Volltext

Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma von Mehta, Ishan, Dayimu, Alimu, Kumar, Satish, Boobier, Clare, Oladipo, Olabode, Burke, David, Olson-Brown, Anna, Yesildag, Pembe, Nobes, Jenny, Brown, Stephanie, Booth, Catherine, Wheater, Matthew, Muller, Daniel, Fountain, Vanessa, Ford, Lucy, Board, Ruth, McGurk, Luke, Twelves, Sophie, Demiris, Nikos, Corrie, Pippa

Volltext

The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer von Abraham, Jean E., Pinilla, Karen, Dayimu, Alimu, Grybowicz, Louise, Demiris, Nikolaos, Harvey, Caron, Drewett, Lynsey M., Lucey, Rebecca, Fulton, Alexander, Roberts, Anne N., Worley, Joanna R., Chhabra, Anita, Qian, Wendi, Vallier, Anne-Laure, Hardy, Richard M., Chan, Steve, Hickish, Tamas, Tripathi, Devashish, Venkitaraman, Ramachandran, Persic, Mojca, Aslam, Shahzeena, Glassman, Daniel, Raj, Sanjay, Borley, Annabel, Braybrooke, Jeremy P., Sutherland, Stephanie, Staples, Emma, Scott, Lucy C., Davies, Mark, Palmer, Cheryl A., Moody, Margaret, Churn, Mark J., Newby, Jacqueline C., Mukesh, Mukesh B., Chakrabarti, Amitabha, Roylance, Rebecca R., Schouten, Philip C., Levitt, Nicola C., McAdam, Karen, Armstrong, Anne C., Copson, Ellen R., McMurtry, Emma, Tischkowitz, Marc, Provenzano, Elena, Earl, Helena M.

Volltext

PARTNER: A randomized, phase II/III trial to evaluate the safety and efficacy of the addition of olaparib to platinum-based neoadjuvant chemotherapy in patients with triple-negativ... von Drewett, Lynsey, Lucey, Rebecca, Pinilla, Karen Andrea, Grybowicz, Louise, Wulff, Jerome, Dayimu, Alimu, Demiris, Nikos, Vallier, Anne-Laure, Qian, Wendi, Machin, Andrea, McAdam, Karen, Roylance, Rebecca, Copson, Ellen, Armstrong, Anne C., Levitt, Nicola, Provenzano, Elena, Tischkowitz, Marc D., McMurtry, Emma, Earl, Helena Margaret, Abraham, Jean

Volltext

Abstract OT2-24-01: PARTNER: Randomised, phase II/III trial to evaluate the safety and efficacy of the addition of olaparib to platinum-based neoadjuvant chemotherapy in triple neg... von Drewett, Lynsey M, Pinilla, Karen A, Grybowicz, Louise, Wulff, Jerome, Dayimu, Alimu, Demiris, Nikolaos, Martin, Jessica, de Pontes, Camila Maida, Johnson, Nicola, Harvey, Caron, Demir, Erdem, Green, Kimberley St John, Jones, James, Young, Gemma, Vallier, Anne-Laure, Qian, Wendi, Machin, Andrea, McAdam, Karen, Roylance, Rebecca, Copson, Ellen R, Armstrong, Anne, Levitt, Nicola, Provenzano, Elena, Tischkowitz, Marc, McMurtry, Emma, Earl, Helena, Abraham, Jean E

Volltext